Researchers have shown in mice that brain cells known as astrocytes are required for a signaling chemical called norepinephrine to modify brain activity, changing the textbook understanding that ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

The FDA has approved Emrelis to treat adults with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Scientists are aiming to determine the composition and topology of physiological Ashwell-Morell receptor ligands. Their findings will help uncover the receptor's still-hidden secrets.